These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28346213)

  • 1. Development and Application of a High-Performance Liquid Chromatography Stability-Indicating Assay for Beyond-Use Date Determination of Compounded Topical Gels Containing Multiple Active Drugs.
    Gorman G; Sokom S; Coward L; Arnold JJ
    Int J Pharm Compd; 2017; 21(2):164-170. PubMed ID: 28346213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Percutaneous Absorption of Ketamine HCl, Gabapentin, Clonidine HCl, and Baclofen, in Compounded Transdermal Pain Formulations, Using the Franz Finite Dose Model.
    Bassani AS; Banov D
    Pain Med; 2016 Feb; 17(2):230-8. PubMed ID: 26352507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the stability of ketoprofen in pluronic lecithin organogel and the determination of an appropriate beyond-use date.
    Peacock GF; Sauvageot J; Addo RT
    Int J Pharm Compd; 2014; 18(4):348-50. PubMed ID: 25474865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compounded Topical Analgesics for Chronic Pain.
    Cline AE; Turrentine JE
    Dermatitis; 2016; 27(5):263-71. PubMed ID: 27649348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of gabapentin in extemporaneously compounded oral suspensions.
    Friciu M; Roullin VG; Leclair G
    PLoS One; 2017; 12(4):e0175208. PubMed ID: 28414771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin permeation and antinociception of topical gabapentin formulations.
    Bryson E; Asbill S; Sweitzer S
    Int J Pharm Compd; 2014; 18(6):504-11. PubMed ID: 25906628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the stability of promethazine hydrochloride in pluronic lecithin organogel and the determination of an appropriate beyond-use date.
    Peacock GF; Sauvageot J
    Int J Pharm Compd; 2014; 18(4):345-7. PubMed ID: 25474864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of gabapentin in SyrSpend SF.
    Sorenson B; Voudrie MA; Gehrig D
    Int J Pharm Compd; 2012; 16(4):347-9. PubMed ID: 23050395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the chemical and physical stability of ketoprofen compounded in various pharmaceutical bases on its topical and transdermal delivery.
    Nornoo AO; Wulz J; Yoon H; Nan Y; Lese M
    Pharm Dev Technol; 2016 Mar; 21(2):204-13. PubMed ID: 25431959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and in vitro evaluation of a pluronic lecithin organogel containing ricinoleic acid for transdermal delivery.
    Boddu SH; Bonam SP; Wei Y; Alexander K
    Int J Pharm Compd; 2014; 18(3):256-61. PubMed ID: 25306775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability Assessment of Topical Amitriptyline Extemporaneously Compounded with Lipoderm Base, PLO Gel Mediflo 30, and Emollient Cream.
    Shakshuki A; Agu RU
    Int J Pharm Compd; 2019; 23(1):82-87. PubMed ID: 30668540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of some hydrophilic excipients on the rate of gabapentin and baclofen lactamization in lyophilized formulations.
    Cutrignelli A; Denora N; Lopedota A; Trapani A; Laquintana V; Latrofa A; Trapani G; Liso G
    Int J Pharm; 2007 Mar; 332(1-2):98-106. PubMed ID: 17071027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compounded ointment results in severe toxicity in a pediatric patient.
    Sullivan RW; Ryzewski M; Holland MG; Marraffa JM
    Pediatr Emerg Care; 2013 Nov; 29(11):1220-2. PubMed ID: 24196095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compounded gabapentin for neuropathic pain: Stability and beyond-use date (BUD) in some commonly used bases.
    Shakshuki A; Yeung P; Agu RU
    J Am Pharm Assoc (2003); 2019; 59(4):514-520. PubMed ID: 30979575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the stability of fluoxetine in pluronic lecithin organogel and the determination of an appropriate beyond-use date.
    Peacock GF; Sauvageot J
    Int J Pharm Compd; 2014; 18(3):253-5. PubMed ID: 25306774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical analgesic combinations for bortezomib neuropathy.
    Prommer EE
    J Pain Symptom Manage; 2009 Mar; 37(3):e3-5. PubMed ID: 19171460
    [No Abstract]   [Full Text] [Related]  

  • 17. Kinetic model for solid-state degradation of gabapentin.
    Zong Z; Qiu J; Tinmanee R; Kirsch LE
    J Pharm Sci; 2012 Jun; 101(6):2123-33. PubMed ID: 22419014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and application of a validated HPLC method for the analysis of dissolution samples of gabapentin drug products.
    Gupta A; Ciavarella AB; Sayeed VA; Khan MA; Faustino PJ
    J Pharm Biomed Anal; 2008 Jan; 46(1):181-6. PubMed ID: 17935923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical Stability and Release Profile of Compounded Gabapentin Containing Pluronic Lecithin Organogel for Neuropathic Pain Management.
    Hong EJ; Sumanasekera W; Le UM
    Int J Pharm Compd; 2022; 26(1):65-71. PubMed ID: 35081046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the stability of acetaminophen in pluronic lecithin organogel and the determination of an appropriate beyond-use date.
    Peacock GF; Sauvageot J
    Int J Pharm Compd; 2012; 16(5):428-30. PubMed ID: 23072202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.